Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1
- PMID: 25714343
- PMCID: PMC4340957
- DOI: 10.1371/journal.pntd.0003500
Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1
Abstract
Leishmania is a digenetic protozoan parasite causing leishmaniasis in humans. The different clinical forms of leishmaniasis are caused by more than twenty species of Leishmania that are transmitted by nearly thirty species of phlebotomine sand flies. Pentavalent antimonials (such as Pentostam or Glucantime) are the first line drugs for treating leishmaniasis. Recent studies suggest that pentavalent antimony (Sb(V)) acts as a pro-drug, which is converted to the more active trivalent form (Sb(III)). However, sensitivity to trivalent antimony varies among different Leishmania species. In general, Leishmania species causing cutaneous leishmaniasis (CL) are more sensitive to Sb(III) than the species responsible for visceral leishmaniasis (VL). Leishmania aquaglyceroporin (AQP1) facilitates the adventitious passage of antimonite down a concentration gradient. In this study, we show that Leishmania species causing CL accumulate more antimonite, and therefore exhibit higher sensitivity to antimonials, than the species responsible for VL. This species-specific differential sensitivity to antimonite is directly proportional to the expression levels of AQP1 mRNA. We show that the stability of AQP1 mRNA in different Leishmania species is regulated by their respective 3'-untranslated regions. The differential regulation of AQP1 mRNA explains the distinct antimonial sensitivity of each species.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.J Antimicrob Chemother. 2010 Mar;65(3):496-507. doi: 10.1093/jac/dkp468. Epub 2010 Jan 12. J Antimicrob Chemother. 2010. PMID: 20067981
-
Comparison of in vitro Resistance of Wild Leishmania İsolates, Which are Resistant to Pentavalent Antimonial Compounds, Against Drugs Used in the Treatment of Leishmaniasis.Turkiye Parazitol Derg. 2020 Mar 20;44(1):12-16. doi: 10.4274/tpd.galenos.2019.6661. Turkiye Parazitol Derg. 2020. PMID: 32212583
-
Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.Int J Parasitol Drugs Drug Resist. 2016 Aug;6(2):133-9. doi: 10.1016/j.ijpddr.2016.04.003. Epub 2016 Jun 4. Int J Parasitol Drugs Drug Resist. 2016. PMID: 27317865 Free PMC article.
-
[Treatment of visceral leishmaniasis in children].Med Trop (Mars). 2007 Feb;67(1):73-8. Med Trop (Mars). 2007. PMID: 17506279 Review. French.
-
Visceral leishmaniasis in clinical practice.J Infect. 1999 Sep;39(2):112-6. doi: 10.1016/s0163-4453(99)90001-4. J Infect. 1999. PMID: 10609527 Review. No abstract available.
Cited by
-
Antimony resistance and gene expression in Leishmania: spotlight on molecular and proteomic aspects.Parasitology. 2024 Jan;151(1):1-14. doi: 10.1017/S0031182023001129. Epub 2023 Nov 28. Parasitology. 2024. PMID: 38012864 Free PMC article. Review.
-
Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates.Biomolecules. 2023 Apr 1;13(4):637. doi: 10.3390/biom13040637. Biomolecules. 2023. PMID: 37189384 Free PMC article. Review.
-
The paradigm of intracellular parasite survival and drug resistance in leishmanial parasite through genome plasticity and epigenetics: Perception and future perspective.Front Cell Infect Microbiol. 2023 Feb 6;13:1001973. doi: 10.3389/fcimb.2023.1001973. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36814446 Free PMC article. Review.
-
Down the membrane hole: Ion channels in protozoan parasites.PLoS Pathog. 2022 Dec 29;18(12):e1011004. doi: 10.1371/journal.ppat.1011004. eCollection 2022 Dec. PLoS Pathog. 2022. PMID: 36580479 Free PMC article. Review.
-
Global distribution of treatment resistance gene markers for leishmaniasis.J Clin Lab Anal. 2022 Aug;36(8):e24599. doi: 10.1002/jcla.24599. Epub 2022 Jul 9. J Clin Lab Anal. 2022. PMID: 35808933 Free PMC article. Review.
References
-
- Ashutosh, Sundar S, Goyal N (2007) Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol 56: 143–153. - PubMed
-
- Sundar S, More DK, Singh MK, Singh VP, Sharma S, et al. (2000) Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 31: 1104–1107. - PubMed
-
- Legare D, Papadopoulou B, Roy G, Mukhopadhyay R, Haimeur A, et al. (1997) Efflux systems and increased trypanothione levels in arsenite-resistant Leishmania . Exp Parasitol 87: 275–282. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
